Low Dose Acute Alcohol Effects on GABA A Receptor Subtypes
Overview
Affiliations
GABA(A) receptors (GABA(A)Rs) are the main inhibitory neurotransmitter receptors and have long been implicated in mediating at least part of the acute actions of ethanol. For example, ethanol and GABAergic drugs including barbiturates and benzodiazepines share many pharmacological properties. Besides the prototypical synaptic GABA(A)R subtypes, nonsynaptic GABA(A)Rs have recently emerged as important regulators of neuronal excitability. While high doses (> or =100 mM) of ethanol have been reported to enhance activity of most GABA(A)R subtypes, most abundant synaptic GABA(A)Rs are essentially insensitive to ethanol concentrations that occur during social ethanol consumption (< 30 mM). However, extrasynaptic delta and beta3 subunit-containing GABA(A)Rs, associated in the brain with alpha4 or alpha6 subunits, are sensitive to low millimolar ethanol concentrations, as produced by drinking half a glass of wine. Additionally, we found that a mutation in the cerebellar alpha6 subunit (alpha6R100Q), initially reported in rats selectively bred for increased alcohol sensitivity, is sufficient to produce increased alcohol-induced motor impairment and further increases of alcohol sensitivity in recombinant alpha6beta3delta receptors. Furthermore, the behavioral alcohol antagonist Ro15-4513 blocks the low dose alcohol enhancement on alpha4/6/beta3delta receptors, without reducing GABA-induced currents. In binding assays alpha4beta3delta GABA(A)Rs bind [(3)H]Ro15-4513 with high affinity, and this binding is inhibited, in an apparently competitive fashion, by low ethanol concentrations, as well as analogs of Ro15-4513 that are active to antagonize ethanol or Ro15-4513's block of ethanol. We conclude that most low to moderate dose alcohol effects are mediated by alcohol actions on alcohol/Ro15-4513 binding sites on GABA(A)R subtypes.
Association Between GABRG2 and Self-Rating of the Effects of Alcohol in a French Young Adult Sample.
Moe J, Bramness J, Bolstad I, Morland J, Gorwood P, Ramoz N Risk Manag Healthc Policy. 2025; 18:291-304.
PMID: 39882063 PMC: 11775821. DOI: 10.2147/RMHP.S483830.
GABA receptor subtypes and benzodiazepine use, misuse, and abuse.
Engin E Front Psychiatry. 2023; 13():1060949.
PMID: 36713896 PMC: 9879605. DOI: 10.3389/fpsyt.2022.1060949.
Chapman C, Nuwer J, Jacob T Front Synaptic Neurosci. 2022; 14:911020.
PMID: 35663370 PMC: 9160301. DOI: 10.3389/fnsyn.2022.911020.
Elucidating Pathway and Anesthetic Mechanism of Action of Clove Oil Nanoformulations in Fish.
Kheawfu K, Pikulkaew S, Wellendorph P, Jorgensen L, Rades T, Mullertz A Pharmaceutics. 2022; 14(5).
PMID: 35631505 PMC: 9147060. DOI: 10.3390/pharmaceutics14050919.
GABA receptors in GtoPdb v.2021.3.
Belelli D, Hales T, Lambert J, Luscher B, Olsen R, Peters J IUPHAR BPS Guide Pharm CITE. 2022; 2021(3).
PMID: 35005623 PMC: 8734037. DOI: 10.2218/gtopdb/F72/2021.3.